Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology. 2005;236(3):789–800.
Article
Google Scholar
Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging. 1993;11(5):617–20.
Article
CAS
Google Scholar
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–32.
Article
CAS
Google Scholar
Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer. 2005;104(4):708–18.
Article
Google Scholar
El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011;197(6):1498–505.
Article
Google Scholar
Hauth EAM, Jaeger HJ, Maderwald S, Muehler A, Kimmig R, Forsting M. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography. Eur J Radiol. 2008;66(2):300–8.
Article
CAS
Google Scholar
Veltman J, Stoutjesdijk M, Mann R, Huisman HJ, Barentsz JO, Blickman JG, et al. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol. 2008;18(6):1123–33.
Article
CAS
Google Scholar
Li L, Wang K, Sun X, Wang K, Sun Y, Zhang G, et al. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer. Med Sci Monit. 2015;21:376–82.
Article
CAS
Google Scholar
Yim H, Kang DK, Jung YS, Jeon GS, Kim TH. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: correlations with dominant stroma type. Magn Reson Imaging. 2016;34(1):60–5.
Article
Google Scholar
Amarnath J, Sangeeta T, Mehta SB. Role of quantitative pharmacokinetic parameter (transfer constant: K(trans)) in the characterization of breast lesions on MRI. Indian J Radiol Imaging. 2013;23(1):19–25.
Article
Google Scholar
Michaely HJ, Morelli JN, Budjan J, Riffel P, Nickel D, Kroeker R, et al. CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE): a new technique for fast time-resolved dynamic 3-dimensional imaging of the abdomen with high spatial resolution. Invest Radiol. 2013;48(8):590–7.
Article
CAS
Google Scholar
Li Z, Ai T, Hu Y, Yan X, Nickel MD, Xu X, et al. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique. J Magn Reson Imaging. 2018;47(1):91–6.
Article
Google Scholar
Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007;17(10):2646–55.
Article
CAS
Google Scholar
Rubesova E, Grell A-S, De Maertelaer V, Metens T, Chao S-L, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging. 2006;24(2):319–24.
Article
Google Scholar
Guo Y, Cai Y-Q, Cai Z-L, Gao Y-G, An N-Y, Ma L, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16(2):172–8.
Article
Google Scholar
Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002;15(6):693–704.
Article
Google Scholar
Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol. 2009;193(6):1716–22.
Article
Google Scholar
Bogner W, Gruber S, Pinker K, Grabner G, Stadlbauer A, Weber M, et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology. 2009;253(2):341–51.
Article
Google Scholar
Bogner W, Weber M, Helbich TH, Trattnig S. Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 30 T. Radiology. 2012;263(1):64–76.
Article
Google Scholar
Suo S, Zhang K, Cao M, Suo X, Hua J, Geng X, et al. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. J Magn Reson Imaging. 2016;43(4):894–902.
Article
Google Scholar
Zhang Y-D, Wu C-J, Wang Q, Zhang J, Wang X-N, Liu X-S, et al. Comparison of utility of histogram apparent diffusion coefficient and R2* for differentiation of low-grade from high-grade clear cell renal cell carcinoma. AJR Am J Roentgenol. 2015;205(2):W193–201.
Article
Google Scholar
Kim EJ, Kim SH, Park GE, Kang BJ, Song BJ, Kim YJ, et al. Histogram analysis of apparent diffusion coefficient at 3.0 T: correlation with prognostic factors and subtypes of invasive ductal carcinoma. J Magn Reson Imaging. 2015.
Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28.
Article
Google Scholar
Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211(1):101–10.
Article
CAS
Google Scholar
Schabel MC, Morrell GR, Oh KY, Walczak CA, Barlow RB, Neumayer LA. Pharmacokinetic mapping for lesion classification in dynamic breast MRI. J Magn Reson Imaging. 2010;31(6):1371–8.
Article
Google Scholar
Jena A, Mehta SB, Taneja S. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans)) in breast cancer diagnosis. J Magn Reson Imaging. 2013;38(3):573–9.
Article
Google Scholar
Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging. 2008;28(5):1157–65.
Article
Google Scholar
Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol. 2011;196(1):210–7.
Article
Google Scholar
Cai H, Liu L, Peng Y, Wu Y, Li L. Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols. BMC Cancer. 2014;14:366.
Article
Google Scholar
Fusco R, Sansone M, Filice S, Granata V, Catalano O, Amato DM, et al. Integration of DCE-MRI and DW-MRI quantitative parameters for breast lesion classification. Biomed Res Int. 2015;2015:237863.
Article
Google Scholar
Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Allison KH, Peacock S, et al. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology. 2012;263(2):374–82.
Article
Google Scholar
Shin HJ, Kim SH, Lee HJ, Gong G, Baek S, Chae EY, et al. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer. NMR Biomed. 2016;29(8):1070–8.
Article
CAS
Google Scholar
Arponen O, Sudah M, Sutela A, Taina M, Masarwah A, Liimatainen T, et al. Gadoterate meglumine decreases ADC values of breast lesions depending on the b value combination. Sci Rep. 2018;8(1):87.
Article
Google Scholar